- Home
- BMRN
as 10-14-2025 4:00pm EST
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
| Founded: | 1996 | Country: | United States |
| Employees: | N/A | City: | NOVATO |
| Market Cap: | 10.0B | IPO Year: | 1999 |
| Target Price: | $93.71 | AVG Volume (30 days): | 2.2M |
| Analyst Decision: | Buy | Number of Analysts: | 18 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 3.40 | EPS Growth: | 154.69 |
| 52 Week Low/High: | $51.57 - $73.51 | Next Earning Date: | 10-28-2025 |
| Revenue: | $3,063,608,000 | Revenue Growth: | 18.36% |
| Revenue Growth (this year): | 13.35% | Revenue Growth (next year): | 9.18% |
Latest BioMarin Pharmaceutical Inc. News
BMRN Breaking Stock News: Dive into BMRN Ticker-Specific Updates for Smart Investing
StockStory
4 days ago
10x Genomics, BioMarin Pharmaceutical, AMN Healthcare Services, Illumina, and Moderna Stocks Trade Down, What You Need To Know
Simply Wall St.
12 days ago
Can BioMarin (BMRN) Turn PALYNZIQ Success Into a Stronger Rare Disease Growth Story?
Insider Monkey
13 days ago
Growth and Pipeline Keep BioMarin Pharmaceutical Inc. (BMRN) Attractive for Investors
Insider Monkey
13 days ago
BioMarin Pharmaceutical Inc. (BMRN) Hits Its 52-Week Low
Zacks
14 days ago
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock
Zacks
a month ago
Why BioMarin Pharmaceutical (BMRN) is a Top Value Stock for the Long-Term
Simply Wall St.
a month ago
A Fresh Look at BioMarin Pharmaceutical (BMRN) Valuation Following New VOXZOGO and PALYNZIQ Clinical Data
Insider Monkey
a month ago
BioMarin Pharmaceutical Inc. (BMRN): A Bull Case Theory
Compare BMRN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BMRN BioMarin Pharmaceutical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.